EVERY Company Inc. Secures Key Patent for Precision Fermentation-Derived Egg Proteins
Author: Precedence Research
EVERY Company Inc., the food technology company based in San Francisco, has received its latest primary patent no. US 12/096,784. It is a space patent about the progression of egg proteins derived from precision fermentation which enhances EVERY’s patent portfolio and fortifies its position as a food technology leader. The patent claims that any food product reclamation purposes should use products that contain recombinant ovalbumin, the primary egg white protein in the food enhancement system, and at least one other edible ingredient. Ovalbumin is about fifty-four percent protein in an egg white, the chief protein that makes an egg useful in applications such as foam, binding, gelling, and nutrition where the egg or egg white is an ingredient.
The patent claims coverage for variants of wild-type ovalbumin and ovalbumin obtained from several bird species in farm environments and cultivated using different yeasts and fungi, with the assistance of various technologies. The patent is significantly broad in product format categories, and functional uses such as hardness, cohesiveness, springiness, chewiness, foam stability, and both dry and aqueous systems of the composition.
EVERY Co-Founder and CEO Arturo Elizondo referred to this patent as a significant achievement for EVERY owing to the multifunctional potential of ovalbumin. The patent comes on the heels of EVERY’s major partnership announcements with Unilever, Grupo Palacios, and Grupo Nutresa as EVERY gears up for mass-market operations.
Precision Fermentation Market Size and Growth 2024 to 2032
The global precision fermentation market size is calculated at USD 3.2 billion in 2024 and is projected to surpass around USD 67.9 billion by 2032. The global market is expanding at a double-digit CAGR of 46% from 2024 to 2032.
Applications of Precision Fermentation and Market Expansion
- Pharmaceutical Applications: Precision fermentation processes have allowed the synthesis of critical therapeutic compounds without any sources of animals.
- Alternative Proteins: Fermentation technologies have led to the development of fermented milk and egg proteins free from animals thus providing a sustainable solution to animal-based dairy and poultry production.
- Novel Food Ingredients: New fermentation processes have introduced new food ingredients such as leghemoglobin (plant-derived heme protein).
- Industry Growth and Investments: It has been observed that industries like food and beverages under precision fermentation have gained a lot of development and growth which shows it has a capability of answering some of the food systems challenges.
New Startups in Fermentation-Enabled Alternative Proteins
- 15 startups launched in 2021, 9 developing dairy products, 3 seafood, and 8 focusing on ingredients and inputs.
- 9 startups are precision fermentation focused, 5 dairy protein creation, 4 developing fats and oils.
- 6 startups are biomass fermentation focused, 3 seafood product development.
- 4 of 7 fermentation companies formed in 2021.
- 88 companies dedicated to fermentation-based protein, lipids, and functional ingredients.
- 70+ companies have a business or product line focused on fermentation-enabled alternative proteins.
Precision Fermentation Market Key Players
- Change Foods
- Geltor, Helania Inc
- Formo
- FUMI Ingredients
- Fybraworks Foods
- Imagindairy Ltd
- Eden Brew
- Impossible Foods Inc
- Melt & Marble
- Motif Foodworks, Inc
- Mycorena, Myco Technology
- New Culture
- Nourish Ingredients
- Perfect Day Inc
- Remilk Ltd
- Shiru Inc
- The Every Co.
- Triton Algae Innovations
Precision Fermentation Market Recent Breakthroughs:
- In September 2024, Phytolon, a startup from Israel that creates natural food colors through precision fermentation, raised an unknown investment from Rich Products Ventures and more funds from other investors EIT-Food, Arkin Holdings, and Yossi Ackerman.
- In June 2024, in alliance with Michelin, DMC Technologies, and Crédit Agricole, Danone is working on developing a platform meant to improve the infrastructure of precision fermentation for companies to address infrastructural concerns.
- In October 2024, Hydrosome Labs, a biotechnology firm from Chicago, carried out a pre-clinical trial on the Hydrosome H2O product, which enhances the delivery of active ingredients to the cells using ultrafine bubbles that support precision fermentation techniques.
We’ve prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344
